The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients

Objective: To clarify whether the serum squamous cell carcinoma antigen (SCCA) levels of patients with inverted papilloma (IP) are different from patients with nasal polyps (NP) and rhinitis. Materials and methods: Serum SCCA levels were measured in 30 patients with IP and 30 patients with NP at one...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chakapan Promsopa, Supakan Suwansri, Paiwon Khuntikij
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2021
Materias:
Acceso en línea:https://doaj.org/article/392aaf5c6bc24a27a863e4b9a7e9f3c3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:392aaf5c6bc24a27a863e4b9a7e9f3c3
record_format dspace
spelling oai:doaj.org-article:392aaf5c6bc24a27a863e4b9a7e9f3c32021-12-02T14:41:00ZThe serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients2095-881110.1016/j.wjorl.2020.02.002https://doaj.org/article/392aaf5c6bc24a27a863e4b9a7e9f3c32021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881120300238https://doaj.org/toc/2095-8811Objective: To clarify whether the serum squamous cell carcinoma antigen (SCCA) levels of patients with inverted papilloma (IP) are different from patients with nasal polyps (NP) and rhinitis. Materials and methods: Serum SCCA levels were measured in 30 patients with IP and 30 patients with NP at one day before surgery and seven days after surgery and measured in 28 patients with rhinitis. Results: Elevated serum SCCA levels (>1.5 ng/ml) were found in 80.0% of patients in the IP group, 6.7% of patients in the NP group and 14.3% of patients in the rhinitis group, which was a significant difference. The medians of serum SCCA levels in the IP, NP and rhinitis groups were 3.9, 0.8 and 1.1 ng/ml, respectively, which was a significant difference. The SCCA level in IP group was not significantly correlated according to Krouse Staging. There was a significant difference in serum SCCA levels between the pre- and postoperative stages in the IP group, at 3.9 and 0.8 ng/ml, respectively, while in the NP group the levels were 0.8 and 1.0 ng/ml, not significantly different. With regard to the IP diagnosis in the IP and NP group based on the SCCA level (>1.5 ng/ml), sensitivity and specificity was 80.0% and 93.3%, respectively. Conclusions: The serum SCCA level in patients with IP was elevated and then it decreased after surgery. This was different from NP and rhinitis patients who mostly had normal levels, which did not change.Chakapan PromsopaSupakan SuwansriPaiwon KhuntikijKeAi Communications Co., Ltd.articleSerum squamous cell carcinoma antigenInverted papillomaNasal polypsRhinitisOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 7, Iss 1, Pp 23-27 (2021)
institution DOAJ
collection DOAJ
language EN
topic Serum squamous cell carcinoma antigen
Inverted papilloma
Nasal polyps
Rhinitis
Otorhinolaryngology
RF1-547
Surgery
RD1-811
spellingShingle Serum squamous cell carcinoma antigen
Inverted papilloma
Nasal polyps
Rhinitis
Otorhinolaryngology
RF1-547
Surgery
RD1-811
Chakapan Promsopa
Supakan Suwansri
Paiwon Khuntikij
The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
description Objective: To clarify whether the serum squamous cell carcinoma antigen (SCCA) levels of patients with inverted papilloma (IP) are different from patients with nasal polyps (NP) and rhinitis. Materials and methods: Serum SCCA levels were measured in 30 patients with IP and 30 patients with NP at one day before surgery and seven days after surgery and measured in 28 patients with rhinitis. Results: Elevated serum SCCA levels (>1.5 ng/ml) were found in 80.0% of patients in the IP group, 6.7% of patients in the NP group and 14.3% of patients in the rhinitis group, which was a significant difference. The medians of serum SCCA levels in the IP, NP and rhinitis groups were 3.9, 0.8 and 1.1 ng/ml, respectively, which was a significant difference. The SCCA level in IP group was not significantly correlated according to Krouse Staging. There was a significant difference in serum SCCA levels between the pre- and postoperative stages in the IP group, at 3.9 and 0.8 ng/ml, respectively, while in the NP group the levels were 0.8 and 1.0 ng/ml, not significantly different. With regard to the IP diagnosis in the IP and NP group based on the SCCA level (>1.5 ng/ml), sensitivity and specificity was 80.0% and 93.3%, respectively. Conclusions: The serum SCCA level in patients with IP was elevated and then it decreased after surgery. This was different from NP and rhinitis patients who mostly had normal levels, which did not change.
format article
author Chakapan Promsopa
Supakan Suwansri
Paiwon Khuntikij
author_facet Chakapan Promsopa
Supakan Suwansri
Paiwon Khuntikij
author_sort Chakapan Promsopa
title The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
title_short The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
title_full The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
title_fullStr The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
title_full_unstemmed The serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
title_sort serum squamous cell carcinoma antigen level in inverted sinonasal papilloma and nasal polyps patients
publisher KeAi Communications Co., Ltd.
publishDate 2021
url https://doaj.org/article/392aaf5c6bc24a27a863e4b9a7e9f3c3
work_keys_str_mv AT chakapanpromsopa theserumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
AT supakansuwansri theserumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
AT paiwonkhuntikij theserumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
AT chakapanpromsopa serumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
AT supakansuwansri serumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
AT paiwonkhuntikij serumsquamouscellcarcinomaantigenlevelininvertedsinonasalpapillomaandnasalpolypspatients
_version_ 1718390045688201216